Photographer Lora Scantling has captured the girls every year since 2014
Each year, three childhood cancer survivors come together to take a picture, not just because they are friends, but to remind themselves — and the world — how strong they are.
In 2014, young Rylie, Rheann, and Ainsley — 3, 6, and 4 years old at the time, respectively — came together for a memorable photo shoot.
In March 2014, photographers Lora Scantling and Christy Goodger took a very special photo of three little girls from Oklahoma. Rheann Franklin, now 9, Ainsley Peters, now 7, and Rylie Hughey, now 6, were all hugging one another tightly with their eyes closed, showing support in their mutual fight against cancer.
The late British writer AA Gill was denied the drug last year as it was not yet approved by the National Health Service
A lung cancer drug which was denied to British food critic AA Gill has been approved for some patients with his type of cancer.
AA Gill died aged 62 last December after being diagnosed with what he proclaimed the ‘full English’ of cancers – lung cancer which has spread to his neck and pancreas with tumours that were inoperable and unsuitable for radiotherapy.
AA Gill had chemotherapy but could not access the immunotherapy drug nivolumab because it was not approved on the NHS.
Researchers find that common jet lag drug could prevent chemotherapy-induced neuropathic pain (CINP)
A jet lag drug could be given to patients to ease the painful side-effects of cancer treatment, according to a study.
Researchers from the University of Edinburgh and the University of Aberdeen in the UK found that a drug — known as melatonin — appeared to prevent pain caused by chemotherapy damage to nerves by blocking the harmful effects on nerve health.
They focused on a common condition known as chemotherapy-induced neuropathic pain (CINP), which causes tingling and pain sensation to touch and cold temperatures that can be severe enough to cause patients to limit their chemotherapy treatment.
Do you know someone amazing? We want to know about them!
We have some exciting news to share! We have launched our very own awards to help shine a light on the amazing things happening with the cancer community.
Aptly named the Spotlight Awards, the awards by Live Better With celebrate the achievements of truly remarkable people, products, and services in the cancer community. Nominated by the public, the winners will be from all walks of life, of all ages, and from all over the world.
We want to celebrate the successes and achievements of everyone in the cancer community who has demonstrated a passion and a commitment to overcoming obstacles and helping others.
Women are turning their breast surgery scars into stunning works of art with mastectomy tattoos
Mastectomies save lives but they also leave physical – and psychological – scars. Survivors traditionally have to choose between living with those scars, or having a breast reconstruction.
But some breast cancer survivors are choosing a third option – adorning their scarred chests with elaborate and colourful tattoos to transform what can often be a landscape of pain into something beautiful and unique.
Also known as a ‘tittoo’, this popular trend is helping women to emotionally heal and feel confident with their new bodies.
Kymriah treats most common type of childhood cancer, but it has a hefty $475,000 price tag
US health regulators have approved the first cancer drug that uses a patient’s own cells to fight cancer.
The Food and Drug Administration (FDA) has for the first time approved a treatment that uses a patient’s own genetically modified cells to attack a type of leukemia, opening the door to what the agency calls “a new frontier” in medicine.
Oncologists described the drug, made by Novartis and marketed as Kymriah, as revolutionary. But it is priced at a shocking $475,000 per treatment.